ELAN - ELANCO ALERT: Bragar Eagel & Squire P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) on behalf of Elanco stockholders. Our investigation concerns whether Elanco has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On June 27, 2024, Elanco issued a press release "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro. The press release stated that Zenrelia is expected to receive FDA approval in the third ...